Essent Biologics’ new hMSC (human mesenchymal stem/stromal cell) product line was recently featured in Drug Discovery & Development magazine

Essent Biologics adipose-derived mesenchymal stem cells (hMSCs)

AlloSource (Centennial, Colo.), a central U.S. provider of allograft providers, has founded a separate nonprofit known as Essent Biologics to provide human-derived biomaterials for research. Essent has recently launched a human mesenchymal stem cells (hMSCs) offering for a range of research applications.

“The mission for the nonprofit is to maximize that gift of donation,” said Derek Mathers, head of business development at Essent Biologics.

Read the full article here